medigraphic.com
ISSN 1561-3062 (Electronic)

2016, Number 4

<< Back Next >>

Revista Cubana de Obstetricia y Ginecología 2016; 42 (4)

The woman with severe preeclampsia who died from postpartum complications

Gashi AM

Language: English
References: 11
Page: 519-523
PDF size: 47.35 Kb.


ABSTRACT

Preeclampsia is clinically defined by hypertension and proteinuria, with or without pathologic edema that occurs after 20 weeks' gestation, but can also present up to 4-6 weeks post-partum. Worldwide, incidence of preeclampsia is 5-14 percent of all pregnancies, while severe preeclampsia can develop to about 25 percent of all cases of preeclampsia. Severe preeclampsia is a pathology characterized by endothelial dysfunction that can often be complicated, and thus may lead to liver and renal failure, disseminated intravascular coagulopathy (DIC), and central nervous system (CNS) abnormalities. Worldwide, preeclampsia and eclampsia is responsible for about 14 percent of maternal deaths per year. We present a case, from our clinic, which has had serious complications after birth and that ended with the death of the patient. Despite the adequate management with the timely diagnosis and therapy, patient died ten days after Caesarean delivery.


REFERENCES

  1. Lagana AS, Favilli A, Triolo O, Granese R, Gerli S. Early serum markers of preeclampsia: are we stepping forward? J Matern Fetal Neonatal Med. 2015:1-5.

  2. Villar J, Betran AP, Gulmezoglu M. Epidemiological basis for the planning of maternal health services. WHO/RHR. 2001.

  3. Khedun SM, Moodley J, Naicker T. Drug management of hypertensive disorders of pregnancy. PharmacolTher. 1997;74(2):221-58.

  4. Sibai BM. Magnesium sulfate prophylaxis in preeclampsia: Lessons learned from recent trials. Am J Obstet Gynecol. 2004;190(6):1520-6.

  5. WHO, 2004. Bethesda, MD. Global Burden of Disease for the Year 2001 by World Bank Region, for Use in Disease Control Priorities in Developing Countries, National Institutes of Health: WHO. Make every mother and child count. 2nd ed. World Health Report, 2005, Geneva:World Health Orga.

  6. Sibai BM, Ramadan MK, Chari RS. Pregnancies complicated by HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): subsequent pregnancy outcome and long-term prognosis. Am J Obstet Gynecol. 1995;172(1 Pt 1):125-9.

  7. Chames MC, Haddad B, Barton JR. Subsequent pregnancy outcome in women with a history of HELLP syndrome at < or = 28 weeks of gestation. Am J Obstet Gynecol. 2003;188(6):1504-7; discussion 1507-8.

  8. Sibai BM, Sarinoglu C, Mercer BM. Eclampsia. VII. Pregnancy outcome after eclampsia and long-term prognosis. Am J Obstet Gynecol. 1992;166(6 Pt 1):1757- 61; discussion 1761-3.

  9. Lopez-Llera M, Hernandez Horta JL. Pregnancy after eclampsia. Am J Obstet Gynecol. 1974;119(2):193-8.

  10. Adelusi B, Ojengbede OA. Reproductive performance after eclampsia. Int J Gynaecol Obstet. 1986;24(3):183-9.

  11. Sibai BM, Mercer B, Sarinoglu C. Severe preeclampsia in the second trimester: recurrence risk and long-term prognosis. Am J Obstet Gynecol. 1991;165(5 Pt 1):1408-12.




2020     |     www.medigraphic.com